NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 126-150 out of 155.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

Public Release: 24-Feb-2014
Journal of General Internal Medicine
Mental health conditions in most suicide victims left undiagnosed at doctor visits
The mental health conditions of most people who commit suicide remain undiagnosed, even though many visit a primary care provider or medical specialist in the year before they die, according to a national study. Among those in the study, 83 percent received health care treatment in the year prior to dying, and they used medical and primary care services more frequently than any other health service. However, a mental health diagnosis was made in less than half (45 percent) of these cases.
NIH/National Institute of Mental Health

Contact: Dwight Angell
dwight.angell@hfhs.org
313-850-3471
Henry Ford Health System

Public Release: 24-Feb-2014
Journal of General Internal Medicine
Preventing suicide should start in a general medical setting
The mental health conditions of most people who commit suicide remain undiagnosed, even though most visit a primary care provider or medical specialist in the year before they die. To help prevent suicides, health care providers should therefore become more attuned to their patients' mental health states and possible suicide ideations. These are the findings of Brian Ahmedani from the Henry Ford Health System in Detroit, Michigan.
NIH/National Institute of Mental Health

Contact: Alexander Brown
alexander.brown@springer.com
917-710-8274
Springer Science+Business Media

Public Release: 24-Feb-2014
Journal of Affective Disorders
Higher risks among perinatal women with bipolar disorder
Women with bipolar disorder often struggle with the illness during and after pregnancy. A new study finds that they were significantly more likely to face important psychiatric and childrearing challenges compared to women who were seeking treatment for other psychiatric disorders.
NIH/National Institute of Mental Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 24-Feb-2014
Diabetes Care
Specialized cognitive therapy improves blood sugar control in depressed diabetes patients
A program of cognitive behavioral therapy that addresses both mood and diabetes self-care led to improved blood sugar control and produced faster relief of depression in patients with poorly controlled type 2 diabetes.
NIH/National Institute of Mental Health

Contact: Kristen Chadwick
kschadwick@partners.org
617-643-3907
Massachusetts General Hospital

Public Release: 23-Feb-2014
Nature
Researchers pinpoint brain region essential for social memory
Researchers have determined that a small region of the hippocampus known as CA2 is essential for social memory, the ability of an animal to recognize another of the same species. A better grasp of the function of CA2 could prove useful in understanding and treating disorders characterized by altered social behaviors, such as autism, schizophrenia, and bipolar disorder. The findings, made in mice, were published today in the online edition of Nature.
NIH/National Institute of Mental Health, Howard Hughes Medical Institute

Contact: Joannie Danielides
jcd2185@columbia.edu
917-539-4924
Columbia University Medical Center

Public Release: 20-Feb-2014
Biological Psychiatry
Study in mice raises question: Could PTSD involve immune response to stress?
Chronic stress that produces inflammation and anxiety in mice appears to prime their immune systems for a prolonged fight, causing the animals to have an excessive reaction to a single acute stressor weeks later, new research suggests.
NIH/National Institute of Mental Health, NIH/National Institute on Aging

Contact: Jonathan Godbout
Jonathan.Godbout@osumc.edu
614-293-3456
Ohio State University

Public Release: 19-Feb-2014
JAMA
Antidepressant holds promise in treating Alzheimer's agitation
An antidepressant medication has shown potential in treating symptoms of agitation that occur with Alzheimer's disease and in alleviating caregivers' stress, according to a multi-site US-Canada study.
NIH/National Institute of Mental Health, NIH/National Institute on Aging

Contact: Kate Richards
media@camh.ca
416-595-6015
Centre for Addiction and Mental Health

Public Release: 18-Feb-2014
JAMA
JAMA study shows medication to treat agitation for Alzheimer's disease shows mixed results
The results of a JAMA study offer a glimmer of hope to families caring for a loved one with Alzheimer's disease. Researchers at the University of Rochester, Johns Hopkins University, and six other academic medical centers found that a high dose of a common antidepressant significantly reduced agitation in patients. However, given potentially concerning side effects of citalopram, researchers say further investigation is needed to determine whether a smaller dose will be as effective.
NIH/National Institute on Aging, NIH/National Institute of Mental Health

Contact: Julie Philipp
julie_philipp@urmc.rochester.edu
585-275-1309
University of Rochester Medical Center

Public Release: 18-Feb-2014
JAMA
Antidepressant holds promise in treating Alzheimer's agitation
The antidepressant drug citalopram, sold under the brand names Celexa and Cipramil and also available as a generic medication, significantly relieved agitation in a group of patients with Alzheimer's disease. In lower doses than those tested, the drug might be safer than antipsychotic drugs currently used to treat the condition, according to results of a clinical trial led by Johns Hopkins researchers that included seven other academic medical centers in the United States and Canada.
NIH/National Institute on Aging, NIH/National Institute of Mental Health

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine

Public Release: 13-Feb-2014
Cell
Broad, MIT researchers reveal structure of key CRISPR complex
Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex -- a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells.
NIH/National Institute of Mental Health, National Institutes of Health

Contact: Haley Bridger
hbridger@broadinstitute.org
617-714-7968
Broad Institute of MIT and Harvard

Public Release: 11-Feb-2014
Molecular Psychiatry
New evidence shows how chronic stress predisposes brain to mental disorders
UC Berkeley biologist Daniela Kaufer and colleagues have shown in rats that chronic stress makes stem cells in the brain produce more myelin-producing cells and fewer neurons, possibly affecting the speed of connections between cells as well as memory and learning. This could explain why stress leads to mental illness, such as PTSD, anxiety and mood disorders, later in life.
NIH/National Institute of Mental Health, Brain & Behavior Research Foundation

Contact: Robert Sanders
rlsanders@berkeley.edu
510-643-6998
University of California - Berkeley

Public Release: 11-Feb-2014
Behavior Therapy
RI Hospital: Cognitive behavioral therapy benefits patients with body dysmorphic disorder
In a recent study, researchers at Rhode Island Hospital found significant benefits of cognitive behavioral therapy as a treatment modality for patients with Body Dysmorphic Disorder (BDD). BDD is a common, often severe, and under-recognized body image disorder that affects an estimated 1.7 percent to 2.4 percent of the population. This study demonstrated significant improvement in patients' BDD symptoms and level of disability, as well as high levels of patient satisfaction with the treatment.
NIH/National Institute of Mental Health

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan

Public Release: 4-Feb-2014
Psychiatric Services
Personal experience, work seniority improve mental health professionals' outlook
One might think that after years of seeing people at their worst, mental health workers would harbor negative attitudes about mental illness, perhaps associating people with mental health issues as less competent or dangerous. But a new study suggests the opposite.
Substance Abuse and Mental Health Services Administration, NIH/National Institute of Mental Health

Contact: Molly McElroy
mollywmc@uw.edu
206-543-2580
University of Washington

Public Release: 4-Feb-2014
Psychiatry Research
Study finds high Rx burden for bipolar patients
Concerned about patients with bipolar disorder needing hospitalization despite treatment with four or more psychotropic medications, a team of researchers sought to quantify the rate of "complex polypharmacy." They found that 36 percent of patients admitted to the hospital with bipolar disorder in 2010 were receiving complex polypharmacy from their community providers The polypharmacy rate was significantly higher for women. Including for other conditions, the average patient was on six medications.
NIH/National Institute of Mental Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 4-Feb-2014
Health Psychology
Happy people, safer sex
In a new study, researchers at Columbia University's Mailman School of Public Health report that HIV-positive men whose moods improved in a given week were more likely to have safe sex than they would in a normal week. In weeks where moods were worse than usual, they were more likely to have unprotected sex. Results appear online in the journal Health Psychology.
NIH/National Institute of Mental Health

Contact: Timothy S. Paul
tp2111@columbia.edu
212-305-2676
Columbia University's Mailman School of Public Health

Public Release: 3-Feb-2014
Health Psychology
Perceived control reduces mortality risk at low, not high, education levels
Personality researchers find having a sense of control over one's life can reduce mortality rates in people who have little education, but a sense of control does not influence mortality rates in people with higher levels of education.
NIH/National Institute of Mental Health, NIH/National Institute on Aging

Contact: Julie Philipp
julie_philipp@urmc.rochester.edu
585-275-1309
University of Rochester Medical Center

Public Release: 29-Jan-2014
JAMA Psychiatry
Less than half of children treated for anxiety achieve long-term relief
Fewer than one in two children and young adults treated for anxiety achieve long-term relief from symptoms, according to the findings of a study by investigators from the Johns Hopkins Children's Center and five other institutions.
NIH/National Institute of Mental Health

Contact: Ekaterina Pesheva
epeshev1@jhmi.edu
410-502-9433
Johns Hopkins Medicine

Public Release: 28-Jan-2014
Journal of Neuroscience
Low levels of pro-inflammatory agent help cognition in rats
Although inflammation is frequently a cause of disease in the body, research from the University of Texas Health Science Center at San Antonio indicates that low levels of a pro-inflammatory cytokine in the brain are important for cognition. Cytokines are proteins produced by the immune system.
NIH/National Institute of Mental Health, Brain and Behavior Research Foundation

Contact: Will Sansom
sansom@uthscsa.edu
210-567-2579
University of Texas Health Science Center at San Antonio

Public Release: 27-Jan-2014
Nature Neuroscience
Permanent changes in brain genes may not be so permanent after all
In normal development, all cells turn off genes they don't need, often by attaching a chemical methyl group to the DNA, a process called methylation. Historically, scientists believed methyl groups could only stick to a particular DNA sequence: a cytosine followed by a guanine, called CpG. But in recent years, they have been found on other sequences, and so-called non-CpG methylation has been found in stem cells, and in neurons in the brain.
NIH/National Institute of Neurological Disorders and Stroke, NIH/National Institute of Environmental Health Sciences, NIH/National Institute of Mental Health, NIH/National Institute of Child Health and Human Development

Contact: Vanessa McMains
vmcmain1@jhmi.edu
410-502-9410
Johns Hopkins Medicine

Public Release: 24-Jan-2014
Perspectives on Psychological Science
Researchers use sensory integration model to understand unconscious priming
Priming, an unconscious phenomenon that causes the context of information to change the way we think or behave, has frustrated scientists as they have unsuccessfully attempted to understand how it works. But, recent failures to replicate demonstrations of unconscious priming have resulted in a heated debate within the field of psychology. In a breakthrough paper, Carnegie Mellon University researchers use a well-established human perception theory to illustrate the mechanisms underlying priming and explain how its effects do not always act as predicted.
National Science Foundation, NIH/National Institute of Mental Health, Pittsburgh Life Sciences Greenhouse Opportunity Fund

Contact: Shilo Rea
shilo@cmu.edu
412-268-6094
Carnegie Mellon University

Public Release: 23-Jan-2014
Journal of Consulting and Clinical Psychology
CWRU study finds depression symptoms and emotional support impact PTSD treatment progress
Researchers at Case Western Reserve University found that during PTSD treatments, rapid improvements in depression symptoms are associated with better outcomes.
NIH/National Institute of Mental Health

Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University

Public Release: 23-Jan-2014
Nature Chemical Biology
Johns Hopkins scientists identify a key to body's use of free calcium
Scientists at Johns Hopkins report they have figured out a key step in how "free" calcium -- the kind not contained in bones -- is managed in the body, a finding that could aid in the development of new treatments for a variety of neurological disorders that include Parkinson's disease.
NIH/National Institute of General Medical Sciences, NIH/National Heart, Lung and Blood Institute, NIH/National Institute of Mental Health, NIH/National Institute on Deafness and Other Communication Disorders

Contact: Catherine Kolf
ckolf@jhmi.org
443-287-2251
Johns Hopkins Medicine

Public Release: 22-Jan-2014
Nature
New studies show that many rare mutations contribute to schizophrenia risk
Researchers from the Broad Institute and several partnering institutions have taken a closer look at the human genome to learn more about the genetic underpinnings of schizophrenia. In two studies published this week in Nature, scientists analyzed the exomes, or protein-coding regions, of people with schizophrenia and their healthy counterparts, pinpointing the sites of mutations and identifying patterns that reveal clues about the biology underlying the disorder.
NIH/National Institute of Mental Health, NIH/National Human Genome Research Institute

Contact: Haley Bridger
hbridger@broadinstitute.org
617-714-7968
Broad Institute of MIT and Harvard

Public Release: 12-Jan-2014
Nature
Scientists solve 40-year mystery of how sodium controls opioid brain signaling
Scientists have discovered how the element sodium influences the signaling of a major class of brain cell receptors, known as opioid receptors. The discovery, from the Scripps Research Institute and the University of North Carolina, suggests new therapeutic approaches to a host of brain-related medical conditions.
National Institutes of Health, NIH/National Cancer Institute, NIH/National Institute for General Medical Sciences, NIH/National Institute of Mental Health

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 9-Jan-2014
JAMA Psychiatry
Novel biomarker approach suggests new avenues to improve schizophrenia disease management
Environmental effects of events such as oxygen deprivation and infections may be preserved as markers in blood that are associated to schizophrenia, according to an international study led by the Virginia Commonwealth University School of Pharmacy's Center for Biomarker Research and Personalized Medicine.
NIH/National Institute of Mental Health

Contact: Eric Peters
petersem@vcu.edu
804-828-0563
Virginia Commonwealth University

Showing releases 126-150 out of 155.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.